Neovasc Inc.

NVCN.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NVCN.TO stands at 110.78M. In comparison, VMD.TO has a market cap of 402.21M. Regarding current trading prices, NVCN.TO is priced at $40.15, while VMD.TO trades at $10.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NVCN.TO currently has a P/E ratio of -1.96, whereas VMD.TO's P/E ratio is 32.66. In terms of profitability, NVCN.TO's ROE is -1.21%, compared to VMD.TO's ROE of +0.05%. Regarding short-term risk, NVCN.TO is less volatile compared to VMD.TO. This indicates potentially lower risk in terms of short-term price fluctuations for NVCN.TO.

NVCN.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NVCN.TO stands at 110.78M. In comparison, PRN.TO has a market cap of 178.82M. Regarding current trading prices, NVCN.TO is priced at $40.15, while PRN.TO trades at $5.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NVCN.TO currently has a P/E ratio of -1.96, whereas PRN.TO's P/E ratio is -3.84. In terms of profitability, NVCN.TO's ROE is -1.21%, compared to PRN.TO's ROE of -0.63%. Regarding short-term risk, NVCN.TO is less volatile compared to PRN.TO. This indicates potentially lower risk in terms of short-term price fluctuations for NVCN.TO.

NVCN.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NVCN.TO stands at 110.78M. In comparison, TMD.TO has a market cap of 128.29M. Regarding current trading prices, NVCN.TO is priced at $40.15, while TMD.TO trades at $1.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NVCN.TO currently has a P/E ratio of -1.96, whereas TMD.TO's P/E ratio is -0.65. In terms of profitability, NVCN.TO's ROE is -1.21%, compared to TMD.TO's ROE of -1.04%. Regarding short-term risk, NVCN.TO is less volatile compared to TMD.TO. This indicates potentially lower risk in terms of short-term price fluctuations for NVCN.TO.

NVCN.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NVCN.TO stands at 110.78M. In comparison, QIPT.TO has a market cap of 99.11M. Regarding current trading prices, NVCN.TO is priced at $40.15, while QIPT.TO trades at $2.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NVCN.TO currently has a P/E ratio of -1.96, whereas QIPT.TO's P/E ratio is -10.95. In terms of profitability, NVCN.TO's ROE is -1.21%, compared to QIPT.TO's ROE of -0.07%. Regarding short-term risk, NVCN.TO is less volatile compared to QIPT.TO. This indicates potentially lower risk in terms of short-term price fluctuations for NVCN.TO.

NVCN.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NVCN.TO stands at 110.78M. In comparison, BLO.CN has a market cap of 67.93M. Regarding current trading prices, NVCN.TO is priced at $40.15, while BLO.CN trades at $0.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NVCN.TO currently has a P/E ratio of -1.96, whereas BLO.CN's P/E ratio is -19.67. In terms of profitability, NVCN.TO's ROE is -1.21%, compared to BLO.CN's ROE of -0.89%. Regarding short-term risk, NVCN.TO is less volatile compared to BLO.CN. This indicates potentially lower risk in terms of short-term price fluctuations for NVCN.TO.

NVCN.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NVCN.TO stands at 110.78M. In comparison, ATE.TO has a market cap of 15.64M. Regarding current trading prices, NVCN.TO is priced at $40.15, while ATE.TO trades at $0.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NVCN.TO currently has a P/E ratio of -1.96, whereas ATE.TO's P/E ratio is -0.84. In terms of profitability, NVCN.TO's ROE is -1.21%, compared to ATE.TO's ROE of -0.50%. Regarding short-term risk, NVCN.TO is less volatile compared to ATE.TO. This indicates potentially lower risk in terms of short-term price fluctuations for NVCN.TO.

NVCN.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NVCN.TO stands at 110.78M. In comparison, MYTC.CN has a market cap of 3.76M. Regarding current trading prices, NVCN.TO is priced at $40.15, while MYTC.CN trades at $0.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NVCN.TO currently has a P/E ratio of -1.96, whereas MYTC.CN's P/E ratio is -3.00. In terms of profitability, NVCN.TO's ROE is -1.21%, compared to MYTC.CN's ROE of +1.29%. Regarding short-term risk, NVCN.TO is more volatile compared to MYTC.CN. This indicates potentially higher risk in terms of short-term price fluctuations for NVCN.TO.

NVCN.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NVCN.TO stands at 110.78M. In comparison, PMED.CN has a market cap of 3.01M. Regarding current trading prices, NVCN.TO is priced at $40.15, while PMED.CN trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NVCN.TO currently has a P/E ratio of -1.96, whereas PMED.CN's P/E ratio is -1.00. In terms of profitability, NVCN.TO's ROE is -1.21%, compared to PMED.CN's ROE of +2.13%. Regarding short-term risk, NVCN.TO is more volatile compared to PMED.CN. This indicates potentially higher risk in terms of short-term price fluctuations for NVCN.TO.

NVCN.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NVCN.TO stands at 110.78M. In comparison, ASTI.CN has a market cap of 275992.00. Regarding current trading prices, NVCN.TO is priced at $40.15, while ASTI.CN trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NVCN.TO currently has a P/E ratio of -1.96, whereas ASTI.CN's P/E ratio is -0.33. In terms of profitability, NVCN.TO's ROE is -1.21%, compared to ASTI.CN's ROE of +0.18%. Regarding short-term risk, NVCN.TO is less volatile compared to ASTI.CN. This indicates potentially lower risk in terms of short-term price fluctuations for NVCN.TO.

NVCN.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NVCN.TO stands at 110.78M. In comparison, IME.CN has a market cap of 162451.00. Regarding current trading prices, NVCN.TO is priced at $40.15, while IME.CN trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NVCN.TO currently has a P/E ratio of -1.96, whereas IME.CN's P/E ratio is -0.19. In terms of profitability, NVCN.TO's ROE is -1.21%, compared to IME.CN's ROE of +0.20%. Regarding short-term risk, NVCN.TO is more volatile compared to IME.CN. This indicates potentially higher risk in terms of short-term price fluctuations for NVCN.TO.

NVCN.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NVCN.TO stands at 110.78M. In comparison, AVBT.CN has a market cap of 123659.00. Regarding current trading prices, NVCN.TO is priced at $40.15, while AVBT.CN trades at $0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NVCN.TO currently has a P/E ratio of -1.96, whereas AVBT.CN's P/E ratio is -0.20. In terms of profitability, NVCN.TO's ROE is -1.21%, compared to AVBT.CN's ROE of +4.09%. Regarding short-term risk, NVCN.TO is more volatile compared to AVBT.CN. This indicates potentially higher risk in terms of short-term price fluctuations for NVCN.TO.